Extracorporeal shock-wave lithotripsy of pancreatic calculi.
Extracorporeal shock-wave lithotripsy (ESWL) has been used to disintegrate pancreatic stones located in the main pancreatic duct for 123 patients with severe chronic pancreatitis. Endoscopic management following ESWL is aimed at restoring the pancreatic flow to the duodenum. Stone disintegration was achieved in 122 patients, whereas a decrease in the main pancreatic duct diameter resulted in 111, and complete clearance of the main pancreatic duct was obtained in 72. Pain relief, complete (40/88) or partial (35/88), correlated significantly with the results of the endoscopic drainage of the main pancreatic duct (e.g., decrease in main pancreatic duct diameter). Relapsing pain was most often related to recurrent pancreatic duct obstruction. Of 76 patients whose body weight had decreased before ESWL, 54 gained weight. Improvement of the exocrine function, evaluated by the [14C]triolein breath test before and 11 months, on the average, after ESWL, was observed in 12 patients among 22 for whom this test was performed before and after treatment. Improvement of the endocrine function after relief of obstruction of the main pancreatic duct was less frequently recorded (4/41). ESWL of pancreatic stones is a new, safe, and highly effective method of facilitating the endoscopic procedures for relief of pancreatic duct obstruction in severe chronic pancreatitis.
Delhaye
M
M
Medicosurgical Department of Gastroenterology, Erasme Hospital, Free University of Brussels, Belgium.
Vandermeeren
A
A
Baize
M
M
Cremer
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D001944:Breath Tests; D002137:Calculi / Q000150:complications / Q000628:therapy*; D002760:Cholangiopancreatography, Endoscopic Retrograde; D003251:Constriction, Pathologic / Q000209:etiology / Q000628:therapy; D004108:Dilatation, Pathologic / Q000209:etiology / Q000628:therapy; D004322:Drainage; D005260:Female; D006801:Humans; D008096:Lithotripsy / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D010182:Pancreatic Diseases / Q000378:metabolism / Q000628:therapy*; D010183:Pancreatic Ducts / Q000473:pathology